Iressa News and Research

RSS
High OOP costs discouraging many cancer patients from filling prescriptions

High OOP costs discouraging many cancer patients from filling prescriptions

USPTO issues Notice of Allowance for menadione to prevent skin rash in patients taking EGFR inhibitors

USPTO issues Notice of Allowance for menadione to prevent skin rash in patients taking EGFR inhibitors

AstraZeneca Canada's IRESSA receives approval for treatment of NSCLC

AstraZeneca Canada's IRESSA receives approval for treatment of NSCLC

Combination treatment strategies may benefit patients with non-small cell lung cancer

Combination treatment strategies may benefit patients with non-small cell lung cancer

AstraZeneca and Dako Denmark A/S enter into collaboration agreement

AstraZeneca and Dako Denmark A/S enter into collaboration agreement

New compound may halt drug-resistant lung cancer

New compound may halt drug-resistant lung cancer

Cost of Avastin a deterrent for non-small-cell lung cancer treatment

Cost of Avastin a deterrent for non-small-cell lung cancer treatment

Memorial Sloan-Kettering Cancer Center awards $50,000 to three young investigators

Memorial Sloan-Kettering Cancer Center awards $50,000 to three young investigators

Winners of Paul Marks Prize 2009

Winners of Paul Marks Prize 2009

Iressa (gefinitib) chemotherapy combination proves safe for head and neck cancer patients

Iressa (gefinitib) chemotherapy combination proves safe for head and neck cancer patients

Cancer drugs erlotinib and gefitinib might treat alcoholism

Cancer drugs erlotinib and gefitinib might treat alcoholism

Gefitinib just as effective as chemotherapy for lung cancer

Gefitinib just as effective as chemotherapy for lung cancer

Circulating tumor cells can reveal genetic signature of dangerous lung cancers

Circulating tumor cells can reveal genetic signature of dangerous lung cancers

Microchip-based device determines the genetic signature of lung tumors

Microchip-based device determines the genetic signature of lung tumors

Report says cancer clinicians should understand and consider the economic impact of new interventions

Report says cancer clinicians should understand and consider the economic impact of new interventions

Targeted therapy can improve outcomes for lung tumors

Targeted therapy can improve outcomes for lung tumors

New mechanism identified for resistance to targeted lung cancer drugs

New mechanism identified for resistance to targeted lung cancer drugs

New methods for treating lung cancer cells that have become resistant to new anti-cancer agents

New methods for treating lung cancer cells that have become resistant to new anti-cancer agents

New test identifies patients who benefit from targeted cancer drugs

New test identifies patients who benefit from targeted cancer drugs

Novel animal model of lung adenocarcinoma

Novel animal model of lung adenocarcinoma